Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

ESMO real world data and digital oncology·2026
Same author

Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.

Biomedicines·2025
Same author

Adrenal Insufficiency During Treatment With Immune-Checkpoint Inhibitors: How to Simplify the Diagnostic Pathway?

Clinical endocrinology·2025
Same author

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

European thyroid journal·2025
Same author

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024
Same author

Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view.

Journal of endocrinological investigation·2024
Same journal

Association of C-reactive protein to albumin ratio with progression of CKD and all-cause mortality in diabetic CKD.

Journal of endocrinological investigation·2026
Same journal

PMOS in black girls and women: from high to low risk.

Journal of endocrinological investigation·2026
Same journal

Inhibition of TGF-β1/Smad signaling reverses the dedifferentiated phenotype of thyroid cancer cells in three-dimensional culture.

Journal of endocrinological investigation·2026
Same journal

lncRNA PANDAR predicts adverse pregnancy outcomes and reflects hyperglycemia-associated cellular stress in gestational diabetes mellitus.

Journal of endocrinological investigation·2026
Same journal

Correction: Early in, early out: reproductive lifespan timing and cardiometabolic risk in women.

Journal of endocrinological investigation·2026
Same journal

Adult mice are more susceptible to high-fat diet-induced visceral adiposity and insulin resistance than juvenile mice.

Journal of endocrinological investigation·2026
See all related articles

Related Experiment Video

Updated: Dec 13, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.0K

Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues.

A Nervo1, A Ragni2, F Retta2

  • 1Oncological Endocrinology Unit, Department of Medical Sciences, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy. alice.nervo@gmail.com.

Journal of Endocrinological Investigation
|August 4, 2020
PubMed
Summary
This summary is machine-generated.

Differentiated thyroid cancer (DTC) frequently metastasizes to bone, leading to poor survival and skeletal events. This review summarizes current evidence on bone metastases (BM) in DTC, focusing on management and unresolved questions.

Keywords:
Cancer managementMetastatic diseaseSkeletal-related eventThyroid cancer

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.5K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

843

Related Experiment Videos

Last Updated: Dec 13, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.0K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.5K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

843

Area of Science:

  • Oncology
  • Endocrinology
  • Nuclear Medicine

Background:

  • Bone metastases (BM) are the second most common metastatic site in differentiated thyroid cancer (DTC).
  • DTC with BM often presents heterogeneous clinical courses, low survival rates, and significant morbidity from skeletal-related events.
  • Current management requires a multimodal approach, including radioiodine therapy, local procedures, and systemic therapies.

Purpose of the Study:

  • To review recent evidence on differentiated thyroid cancer with bone metastases (BM).
  • To analyze key issues including pathophysiology, prognostic factors, imaging, and clinical management of DTC-BM.
  • To highlight unmet needs and future research directions in DTC-BM.

Main Methods:

  • Literature review of recent evidence on differentiated thyroid cancer and bone metastases.
  • Analysis of pathophysiology, prognostic factors, imaging modalities (anatomic and functional), and treatment strategies.
  • Synthesis of data from existing cohort studies, acknowledging limitations such as long assembly times and small sample sizes.

Main Results:

  • DTC with BM poses significant clinical challenges, necessitating personalized and multimodal treatment strategies.
  • Existing studies on DTC-BM are limited, often combining data over long periods and not always distinguishing bone metastases specifically.
  • Effective management requires careful evaluation of prognostic factors and appropriate use of imaging and therapies.

Conclusions:

  • Management of differentiated thyroid cancer with bone metastases is complex and requires a tailored, multidisciplinary approach.
  • Further prospective studies are needed to better understand the clinical course, prognostic factors, and optimal treatment of DTC-BM.
  • Addressing the heterogeneity and challenges in DTC-BM is crucial for improving patient outcomes and quality of life.